Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/8/2020
SIETES contiene 93082 citas

 
 
 1 a 14 de 14 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Fugh-Berman A. Herb-drug interactions. Lancet 2000;355:134-8. [Ref.ID 48758]
2.
Anónimo. Anthranoids, herbal medicines and carcinogenic potential. Germany. WHO Drug Information 1997;11:19. [Ref.ID 41850]
3.
Anónimo. Laxatives containing aloe, bisacodyl, cascara sagrada and senna. United States of America. WHO Pharmaceuticals Newsletter 1998;9-10:3. [Ref.ID 41539]
4.
Anónimo. Laxatives containing dantron - voluntary withdrawal. Canada. WHO Pharmaceuticals Newsletter 1998;1-2:4. [Ref.ID 37460]
5.
Wise J. Expensive laxatives not necessarily best. BMJ 1998;316:93. [Ref.ID 36469]
7.
Anónimo. Laxatives: reclassification of common ingredients. WHO Drug Information 1996;10:189. [Ref.ID 31396]
8.
Siegers CP. Anthranoid laxatives and colorectal cancer. Trends Pharmacol Sci 1992;13:229-31. [Ref.ID 17560]
9. Cita con resumen
Nolan T, Debelle G, Oberklaid F, Coffey C. Randomised trial of laxatives in treatment of childhood encorpresis. Lancet 1991;338:523-7. [Ref.ID 16135]
10.
Bevers U, Spengler U, Pape GR. Hepatitis after chronic abuse of senna. Lancet 1991;337:372-3. [Ref.ID 15964]
11.
Anónimo. Laxatives: replacing danthron. Drug Ther Bull 1988;26:53-6. [Ref.ID 12355]
12.
Upton DR, Taylor JK, Holmes GKT, Poston J W. Effects of withdrawal of co-danthramer on use of laxatives in a district general hospital. BMJ 1988;297:1446-7. [Ref.ID 11999]
13. Cita con resumen
Bateman DN, Smith JM. A policy for laxatives. BMJ 1988;297:1420-1. [Ref.ID 11996]
14.
Thompson WG. Laxatives: clinical pharmacology and rational use. Drugs 1980;19:49-58. [Ref.ID 5331]
Seleccionar todas
 
 1 a 14 de 14